Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionAditya Puri’s induction adds heft to Solara Pharma's growth plans

    Aditya Puri’s induction adds heft to Solara Pharma's growth plans

    The company whose revenue grew at an average annual pace of 16.6 percent in the three years to FY21 aims to accelerate the growth rate to 25 percent in FY21-25.

    R. Sree Ram
    August 06, 2021 / 14:14 IST
    Aditya Puri
    • PRO Panorama

      Moneycontrol Pro Panorama | India's US LPG Import Pact: Strategic diversification or bargaining chip?

      Nov 18, 2025 / 03:09 PM IST

      Moneycontrol's Pro Panorama November 18 edition: India's October trade deficit balloons and gold rush give a different story, mark...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts